New approach uncovers plaque-associated lipids in Alzheimer's disease models, highlighting lipidomic alterations.
The progressive accumulation of amyloid beta (Aβ) plaques is a hallmark of Alzheimer’s disease (AD). However, the biochemical mechanisms of their formation and the consequences associated with plaque formation remain elusive. We report here a new approach for discovering and mapping region-specific, plaque-associated lipids with large molecular coverage including isomers. We describe a multimodal framework that integrates matrix assisted laser desorption/ionization with laser-induced postionization (MALDI-2) mass spectrometry imaging, trapped ion mobility spectrometry-based spatial lipidomics and fluorescence microscopy. Our approach offers significantly enhanced detectability and spatial-chemical resolution, and a computational pipeline for multimodal image co-registration and discovery of plaque-altered lipids. Here, we present a method to reveal plaque-associated and brain-region-specific lipidomic changes with striking heterogeneity among individual Aβ plaques across and within different regions. Integration of our data with existing spatial transcriptomics data suggests that region-specific accumulation of simple gangliosides is likely driven by lysosomal degradation of complex species. Together, this work provides both a powerful analytical framework and new biological insight into lipid alterations within the Aβ plaque microenvironment.
No takes yet. Share an insight, caveat, or question.
Trinklein et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: